5 Things You Need to Know About Electronic Health Records
Can electronic health record (EHR) integration improve residents of nursing homes’ health outcomes, reduce avoidable hospitalizations and medication errors? Can EHRs also reduce system inefficiencies resulting in cost savings?
According to the Leading Age CAST Report, these are the top five findings that can help answer those questions.
1. EHRs are a key driver to high quality health care.
With accurate data, reporting and clinical decision support tools, these capabilities are essential to improving care quality, driving efficiencies, reducing hospital readmissions and strengthening partnerships with other care providers.
2. Communication is essential for successful implementation.
It is important to develop strong working relationships and shared communication between clinical and technology team members. Input from both sides ensures success in the launch of the EHR.
3. EHR information exchange is the trend of the future.
The movement to have electronic health information in an electronic format, readily available for other health care providers is the trend of the future. The care of a patient is no longer an isolated occurrence by each provider, but rather a continuum of care.
4. Health information exchange improves patient safety.
Patient information provided by clinicians during resident transfer can improve the quality of care and therefore a patient’s safety. Automated clinical and decision support tools can improve the quality and safety components of managing and coordinating care for older, disabled patients with complex medical conditions.
5. Providers should address challenges to health information exchange.
Varying degrees of technology adoptions, compliance standards, interoperability capacity and standards are all components that pose challenges to the fluid implementation of fully informed transitions of care between hospitals and long term and post acute settings.
NHS opens 8 clinical trial sites to assess cancer treatment
The UK's National Health Service (NHS) is opening eight clinical trial sites to assess patients' responses to personalised cancer therapy.
The trials will analyse how patients diagnosed with advanced melanoma or non-small cell lung cancer respond to immunotherapy, to help predict their response to treatment. They will be hosted at Gloucestershire Hospitals NHS Foundation Trust facilities.
Immunotherapy helps the body's own immune system fight cancer, but while it has achieved good results for some cancer patients, it is not successful for everyone. Finding ways to predict which people will respond to the treatment is a major area of research.
OncoHost, an oncology startup, will provide advanced machine learning technology to develop personalised strategies aiming to improve the success rate of the cancer therapy. The trials will contribute to OncoHost’s ongoing PROPHETIC study, which uses the company’s host response profiling platform, PROphet®.
“Immunotherapy has achieved excellent results in certain situations for several cancers, allowing patients to achieve longer control of their cancer with maintained quality of life and longer survival,” said Dr David Farrugia, Consultant Medical Oncologist at NHS, and chief investigator of all eight NHS clinical trial sites.
“However, success with immunotherapy is not guaranteed in every patient, so this PROPHETIC study is seeking to identify changes in proteins circulating in the blood which may help doctors to choose the best treatment for each patient."
"I am excited that Gloucestershire Oncology Centre and its research department have this opportunity to contribute to this growing field of research and I am determined that our centre will make a leading national contribution in patient recruitment.”
Previous studies in the US and Israel have shown that PROphet® has high accuracy in predicting how patients with cancer will respond to various therapies.